At Hearing, Warren Pushes for Increase in U.S. Drug Manufacturing Production

At a hearing of the Senate Special Committee on Aging, U.S. Senator Elizabeth Warren (D-Mass.) raised concerns about the vulnerabilities of the U.S. drug supply chain, highlighting the risks of foreign-made pharmaceuticals and advocating for greater investments in U.S. manufacturing.